Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

5.86USD
23 Aug 2019
Change (% chg)

$0.05 (+0.86%)
Prev Close
$5.81
Open
$5.78
Day's High
$5.89
Day's Low
$5.75
Volume
7,984
Avg. Vol
308,439
52-wk High
$14.00
52-wk Low
$4.82

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Wills

65 2015 Independent Chairman of the Board

Sujal Shah

45 2017 President, Chief Executive Officer, Director

Charles McWherter

64 Senior Vice President, Chief Scientific Officer

Daniel Menold

49 2017 Vice President - Finance

Paul Quinlan

56 2017 General Counsel, Corporate Secretary